key: cord-0712500-q5fsl75u
authors: Annie, Frank H.; Alkhaimy, Haytham; Nanjundappa, Aravinda; Elashery, Ahmad
title: Association between Myocarditis and Mortality in COVID-19 Patients in a Large Registry
date: 2021-12-27
journal: Mayo Clin Proc Innov Qual Outcomes
DOI: 10.1016/j.mayocpiqo.2021.12.006
sha: 27e6f0f4dd1573778e9e5cb74f58db7ef0325491
doc_id: 712500
cord_uid: q5fsl75u

Objective To present a large registry data assessing the association between myocarditis and mortality in patients with SARS-CoV-2 infection. Patients and Methods The researchers identified adult patients aged 18-90 years with COVID-19 diagnosis in the TriNetX (COVID-19 research network) database between January 20, 2020, and December 9, 2020. These patients were then divided into those who had a positive myocarditis diagnosis and those who did not. The researchers compared all-cause mortality between propensity-matched (PSM) pairs of patients in both groups. Results Total of 259,352 patients with COVID-19 diagnosis were included in the study. Of those patients, 383 (0.01%) had myocarditis diagnosis, while 258,969 (99.9%) did not have myocarditis diagnosis during their hospital stay. Patients were more male in the myocarditis group (58.75% vs. 44.73%, P < 0.001). As to the PSM cohorts, 383/383 were matched, and the all-cause mortality was 13.4 % vs. 4.2% (P < 0.001) at 30 days. A Kaplan-Meier survival analysis was also statistically significant (P < 0.001) at 30 days. Conclusion In a large multinational database of COVID-19 patients, we observed an association between myocarditis diagnosis and increased mortality. Further prospective studies are recommended to further assess myocarditis outcomes in COVID-19 patients and treatment options.

Coronavirus disease 2019 (COVID-19) continues to be a challenging global pandemic. The 59 total number of COVID-19 cases is approaching 100 million, and 25 millions of those cases 60 are in the US [1] . Recent studies have indicated that this virus often affects the cardiovascular 61 system [2 -4] . Myocarditis has been identified as a consequence of COVID-19's effect on the 62 cardiovascular system and can even be seen in asymptomatic patients [2, 3] . Myocarditis is 63 often underdiagnosed with COVID-19 diagnosis due to lack of diagnostic modalities. Using 64 cardiac MRI, the incidence of cardiac involvement with COVID-19 diagnosis is variable in the literature ranging from 1.4% in mild to moderate symptomatic athletes [5] to 78% in other 66 study by Puntmann et al [6] . Several studies have investigated the impact of cardiovascular 67 involvement as a prognostic factor for the morbidity and mortality of COVID-19 [7-9]. Based 68 on data from an international registry database, this paper therefore presents the impact of 69 myocarditis as a prognostic factor for the mortality and hospital stays of confirmed COVID- 

We used the TriNetX platform to assess COVID-19 patients with a lab-confirmed SARS-74 CoV-2 diagnosis and a confirmed myocarditis diagnosis. Additional sensitivity analyses used 75 a negative control of unrelated bleeding with no known relationship. Propensity matching was 76 also used to control for literature-driven covariates. Table 1 ].

The platform uses a logistic regression to obtain listed propensity scores for each of The subset suggests that CAD, hypertension, or diabetes comorbidities influence all-cause 147 mortality between the two groups less than myocarditis. Finally, no difference in the 148 falsification of the total cohort was observed (0% vs. 0%), suggesting the absence of a 149 significant unmeasured confounder that would affect the primary outcome. 

Johns Hopkins Coronavirus Resource Center

Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy 224 cases

Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from 229 coronavirus disease 2019 (COVID-19)

Cardiovascular magnetic resonance findings in competitive athletes 233 recovering from COVID-19 infection

Evaluation for Myocarditis in 236

Competitive Student Athletes Recovering From Coronavirus Disease

Magnetic Resonance Imaging

Lavie CJ, Sanchis-Gomar F, Lippi G. Cardiac Injury in COVID-19-Echoing

Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus 308 disease 2019 (COVID-19): Evidence from a meta-analysis